Navigating the Complexities of Diabetes Insipidus Worsened by Primary Polydipsia: A Case Report
Novelty in Biomedicine,
Vol. 14 No. 1 (2026),
8 February 2026
,
Page 60-64
https://doi.org/10.22037/nbm.v14i1.50380
Abstract
Background: Fluid-electrolyte balance is regulated within a narrow range in diabetes insipidus (DI). Coexisting Primary Polydipsia and the related phenomenon of hyponatremia cause considerable mortality and morbidity.
Cases Report: A 70-year-old woman with a history of central diabetes insipidus was referred to our center with a provisional diagnosis of acute-onset hyponatremia due to increased usage of DDAVP spray, who was admitted and treated carefully. According to daily monitoring of electrolytes and urine output, switching from spray to nightly melt DDAVP administration, the patient continued to display symptoms of polyuria, polydipsia, and low sodium levels. It led to a psychiatric consultation due to suspicion of accompanying Primary Polydipsia after experiencing a stressful event.
Prescription of anti-anxiety and sedative medications showed successful resolution of hyponatremia, highlighting the importance of personalized strategies in managing the multifactorial aspects of DI and PP.
Conclusion: This case underscores the complexities and potential remedies for handling DI in patients with underlying psychiatric conditions, emphasizing the necessity of a collaborative approach to optimize patient outcomes.
- Diabetes Insipidus
- Primary Polydipsia
- Fluid Electrolyte Balance
How to Cite
References
1. Christ-Crain M, Bichet DG, Fenske WK, Goldman MB, Rittig S, Verbalis JG, et al. Diabetes insipidus. Nat Rev Dis Primers. 2019;5(1):54.
2. Moeller HB, Rittig S, Fenton RA. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev. 2013;34(2):278-301.
3. Sailer CO, Winzeler B, Christ-Crain M. Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy. Swiss Med Wkly. 2017;147:w14514.
4. Kruse D, Pantelis C, Rudd R, Quek J, Herbert P, McKinley M. Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin II receptor blocking drug (irbesartan). Aust N Z J Psychiatry. 2001;35(1):65-8.
5. Refardt J, Winzeler B, Christ-Crain M. Diabetes insipidus: an update. Endocrinol Metab Clin North Am. 2020;49(3):517-31.
6. Behan LA, Sherlock M, Moyles P, Renshaw O, Thompson CJ, Orr C, et al. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study. Eur J Endocrinol. 2015;172:243-50.
7. Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(Suppl 1):S1-42.
8. Verghese C, de Leon J, Josiassen RC. Problems and progress in the diagnosis and treatment of polydipsia and hyponatremia. Schizophr Bull. 1996;22(3):455-64.
9. Kotagiri R, Kutti Sridharan G. Primary polydipsia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
10. Brookes G, Ahmed AG. Pharmacological treatments for psychosis-related polydipsia. Cochrane Database Syst Rev. 2006;(4):CD003544.
11. Costanzo ES, Antes LM, Christensen AJ. Behavioral and medical treatment of chronic polydipsia in a patient with schizophrenia and diabetes insipidus. Psychosom Med. 2004;66(2):283-6.
12. Goldman MB. A rational approach to disorders of water balance in psychiatric patients. Hosp Community Psychiatry. 1991;42:488-94.
13. Kathol RG, Wilcox JA, Turner RD, Kronfol Z, Olson SC. Pharmacologic approaches to psychogenic polydipsia: case reports. Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(1):95-100.
14. Wilson TK, Tripp J. Buspirone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
- Abstract Viewed: 58 times
- pdf Downloaded: 29 times